Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03461536 · ClinicalTrials.gov registry record · NA
Ultrasound First Clinical Decision Support for Suspected Nephrolithiasis
A NA study of Nephrolithiasis, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 388
- Enrollment target
- 1
- Study location
NCT03461536: Completed NA study of Nephrolithiasis, sponsored by University of California, San Francisco.
NCT03461536 is a NA study of Nephrolithiasis that has completed, run by University of California, San Francisco. The registered enrollment target is 388 participants, above the 100-participant average among 16 other Nephrolithiasis trials with a reported enrollment target (288% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03461536, a NA study of Nephrolithiasis, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 388 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized trial to determine the effectiveness of a clinical decision support tool on image ordering for patients with suspected nephrolithiasis. Patients who present with acute unilateral flank or abdominal pain in whom emergency department providers suspect nephrolithiasis will receive either the clinical decision support tool or no tool (usual care).
Primary Outcome
Whether the patient received CT scan
Conditions Studied
Interventions
- BEHAVIORAL Ultrasound-first Clinical Decision Support tool
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 388 participants |
| Start Date | 2019-01-02 |
| Est. Completion | 2019-12-19 |
| Phase | NA |
What the finished NCT03461536 record still lists
NCT03461536 is an interventional study that assigns participants to a tested intervention. The registered 388 participants enrollment target is mid-sized for trials with a published cap, above the 100-participant average among 16 other Nephrolithiasis trials with a reported enrollment target (288% higher).
The record links to 1 condition, with Nephrolithiasis appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound-first Clinical Decision Support tool is the first listed.
NCT03461536 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03461536 about?
NCT03461536 is a clinical study titled "Ultrasound First Clinical Decision Support for Suspected Nephrolithiasis". This is a randomized trial to determine the effectiveness of a clinical decision support tool on image ordering for patients with suspected nephrolithiasis. Patients who present with acute unilateral flank or abdominal pain in whom emergency department providers suspect nephrolithiasis will receive ...
What is the current status of trial NCT03461536?
This trial is currently completed. It is a NA study. The enrollment target is 388 participants. The study started on 2019-01-02. Estimated completion is 2019-12-19.
What conditions does trial NCT03461536 study?
This clinical trial studies the following conditions: Nephrolithiasis.
What interventions are being tested in trial NCT03461536?
The interventions under investigation include: Ultrasound-first Clinical Decision Support tool (BEHAVIORAL).
Who is sponsoring clinical trial NCT03461536?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03461536 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nephrolithiasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03461536's enrollment target sits among peer trials
388 1st of 16 higher than 16 of 16 other Nephrolithiasis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nephrolithiasis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
-
Thulium Fiber Laser (TFL) vs Thulio Pulsed Thulium:YAG (p-Tm:YAG)
RECRUITING · NA
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
RECRUITING · NA
-
Evaluation of Genetic Abnormalities Amongst Calcium Phosphate Stone Formers
RECRUITING · NA
-
Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04092010 · 388 participants · NA
Improving Preschool Outcomes by Addressing Maternal Depression in Head Start
- NCT05157880 · 388 participants · NA
Building Resiliency in Dyads of Patients With an ANI Admitted to the Neuro-ICU and Their Informal Caregivers
- NCT05748613 · 388 participants · NA
Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's
- NCT06374277 · 388 participants · NA
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI